Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrea Vilarrubi
Institution:
Josep Carreras Leukaemia Research Institute
Observed institution:
Josep Carreras Leukaemia Research Institute
ORCID:
0000-0002-2930-3246
Observed ORCID:
0000-0002-2930-3246
OpenAlex ID:
A5059168658
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
2021
·
Octavio A. Romero
, Andrea Vilarrubi
, et al.
·
Nature Communications
·
72
MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer
2023
·
Juan J. Alburquerque-Bejar
, Pablo Navajas-Chocarro
, et al.
·
Cell Reports Medicine
·
57
PDF
Supplementary Table S1 from SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption
2026
·
Andrea Vilarrubi
, Gabriela Guillén
, et al.
Data from SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption
2026
·
Andrea Vilarrubi
, Gabriela Guillén
, et al.
Supplementary Figure S4 from SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption
2026
·
Andrea Vilarrubi
, Gabriela Guillén
, et al.
Supplementary Table S3 from SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption
2026
·
Andrea Vilarrubi
, Gabriela Guillén
, et al.
Supplementary Figure S6 from SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption
2026
·
Andrea Vilarrubi
, Gabriela Guillén
, et al.
Supplementary Table S2 from SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption
2026
·
Andrea Vilarrubi
, Gabriela Guillén
, et al.
Supplementary Figure S1 from SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption
2026
·
Andrea Vilarrubi
, Gabriela Guillén
, et al.
Supplementary Table S4 from SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption
2026
·
Andrea Vilarrubi
, Gabriela Guillén
, et al.
Supplementary Figure S2 from SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption
2026
·
Andrea Vilarrubi
, Gabriela Guillén
, et al.
Supplementary Figure S5 from SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption
2026
·
Andrea Vilarrubi
, Gabriela Guillén
, et al.
Supplementary Figure S3 from SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption
2026
·
Andrea Vilarrubi
, Gabriela Guillén
, et al.
SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption
2026
·
Andrea Vilarrubi
, Gabriela Guillén
, et al.
·
Cancer Research
Abstract 3277: SWI/SNF inactivation vulnerability
2022
·
Andrea Vilarrubi
, Fernando Setien
, et al.
·
Cancer Research
Show more works
View as search
Works count:
15
Citation count:
129
H-index:
2
I10-index:
2
Year
Topic
Type